Bullish
Maze Therapeutics to Participate in Two Upcoming Investor Conferences
Maze Therapeutics, Inc. (Nasdaq: MAZE) announced that its CEO, Jason Coloma, Ph.D., will participate in two investor conferences: the 2026 Jefferies G...